Skip to main content

Advertisement

SpringerLink
Log in

Caffeine has the capacity to stimulate calcium release in organ culture of neonatal mouse calvaria

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

In view of the possible association between ingestion of caffeine (a constituent of coffee, tea, and several beverages) and osteoporosis, we have studied the effect of caffeine on bone resorption in vitro. Caffeine caused a dose-dependent increase of the spontaneous release of 45Ca from neonatal mouse calvarial bones. The effect of caffeine was less pronounced than that of parathyroid hormone (PTH), but of the same magnitude as that of theophylline, a structurally related methylxanthine. The enhancement of 45Ca release induced by caffeine and PTH was observed in 5 days culture. In 2 days culture, however, only PTH stimulated mineral mobilization. The delayed stimulatory effect of caffeine in long-term cultures was abolished by indomethacin and flurbiprofen. In indomethacin-treated bones, however, caffeine potentiated the stimulatory effect on 45Ca release induced by choleratoxin and forskolin. In contrast, caffeine did not potentiate 45Ca release stimulated by PTH. These data show that caffeine can stimulate calcium release from bone in vitro and that this effect is due to potentiation of a stimulatory action of a bone resorptive agonist acting via the adenylate cyclase-cyclic AMP system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Spiller GA (1984) The methylxanthine beverages and foods chemistry, consumption, and health effects. Alan R. Liss, New York

    Google Scholar 

  2. Daniell HW (1976) Osteoporosis of the slender smoker: vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch Intern Med 136:298–304

    Google Scholar 

  3. Heaney RP, Recker RR (1972) Effect of nitrogen, phosphorus and caffeine on calcium balance in women. J Lab Clin Med 99:46–55

    Google Scholar 

  4. Yano K, Heilbrun LK, Washich RO, Hankin JH, Vogel JM (1985) The relationship between diet and bone mineral content of multiple skeletal sites in elderly Japanese-American men and women living in Hawaii. Am J Clin Nutr 42:877–888

    Google Scholar 

  5. Massey LK, Wise K (1984) The effect of dietary caffeine on urinary calcium, magnesium, sodium and potassium in healthy young females. Nutr Res 4:43–50

    Google Scholar 

  6. Massey LK, Berg TA (1985) The effect of dietary caffeine on urinary excretion of calcium, magnesium, phosphorus, sodium, potassium, chloride and zinc in healthy males. Nutr Res 5:1281–1284

    Google Scholar 

  7. Whiting SJ, Whitney HL (1987) Effect of dietary caffeine and theophylline on urinary calcium excretion in the adult rat. J Nutr 117:1224–1228

    Google Scholar 

  8. Yeh JK, Aloia JF, Semla HM, Chen SY (1986) Influence of injected caffeine on the metabolism of calcium and the retention and excretion of sodium, potassium, phosphorus, magnesium, zinc, and calcium in rats. J Nutr 116:273–280

    Google Scholar 

  9. Colin AA, Kraiem Z, Kahana L, Hochberg Z (1984) Effects of theophylline on urinary excretion of cyclic AMP, calcium, and phosphorus in human subjects. Miner Electrolyte Metab 10: 359–361

    Google Scholar 

  10. Lindsay R, Dempster DW (1985) Osteoporosis: current concepts. Bull Acad Med 61:307–322

    Google Scholar 

  11. Massey LK (1991) Perspectives: caffeine and bone. Directions for research. J Bone Miner Res 11:1149–1152

    Google Scholar 

  12. Riggs BL, Melton LJ III (1986) Involutional osteoporosis. New Engl J Med 314:1676–1685

    Google Scholar 

  13. Marel GM (1983) Osteoporosis in the elderly—an overview. Ir J Med Sci 152(suppl 7):18–26

    Google Scholar 

  14. Wells H, Lloyd W (1967) Effects of theophylline on the serum calcium of rats after parathyroidectomy and administration of parathyroid hormone. Endocrinology 81:139–144

    Google Scholar 

  15. Herrmann-Erlee MPM, van der Meer JM (1974) The effects of dibutyryl cyclic AMP, aminophylline and propranolol on PTH-induced bone resorption in vitro. Endocrinology 94:424–434

    Google Scholar 

  16. Ivey JL, Wright DR, Tashjian AH Jr (1976) Bone resorption in organ culture. Inhibition by the divalent cation ionophores A23187 and X-537A. J Clin Invest 58:1327–1338

    Google Scholar 

  17. Lerner U, Gustafson GT (1981) Delayed stimulatory effect of cyclic AMP on bone resorptin in vitro. Acta Endocrinol 97:281–288

    Google Scholar 

  18. Lerner U, Ransjö M, Fredholm BB (1986) Comparative study of the effect of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation. Biochem Pharmacol 35:4177–4189

    Google Scholar 

  19. Holtrop ME, Raisz LG (1979) Comparison of the effects of 1,25-dihydroxycholecalciferol, prostaglandin E2, and osteoclast-activating factor with parathyroid hormone on the ultrastructure of osteoclasts in cultured long bones of fetal rats. Calcif Tissue Int 29:201–205

    Google Scholar 

  20. Lerner U, Hänström L, Fredholm BB (1985) Diphenylhydantoin inhibits parathyroid hormone and prostaglandin E2-stimulated bone resorption in mouse calvaria without affecting cyclic AMP formation. J Oral Pathol 14:644–653

    Google Scholar 

  21. Klein DC, Raisz LG (1971) Role of adenosine-3′5′-monophosphate in the hormonal regulation of bone resorption: studies with cultured fetal bone. Endocrinology 89:818–826

    Google Scholar 

  22. Lerner U (1980) Inhibition of bone resorption and lysosomal enzyme release from calvarial bones cultured for 24 hours: synergism between cyclic AMP analogues and phosphodiesterase inhibitors. Acta Endocrinol 94:138–144

    Google Scholar 

  23. Bergman EA, Newbrey JW, Massey LK (1988) Caffeine does not cause in vitro calcium loss from neonatal mouse calvaria. Calcif Tissue Int 43:281–283

    Google Scholar 

  24. Lerner UH (1987) Modifications of the mouse calvarial technique improve the responsiveness to stimulators of bone resorption. J Bone Miner Res 2:375–383

    Google Scholar 

  25. Ljunggren Ö, Ransjö M, Lerner UH (1991) In vitro studies on bone resorption in neonatal mouse calvaria using a modified dissection technique giving four samples of bone from each calvaria. J Bone Miner Res 6:543–550

    Google Scholar 

  26. Ljunggren Ö, Lerner UH (1990) Evidence for B1 bradykinin-receptor-mediated prostaglandin formation in osteoblasts and subsequent enhancement of bone resorption. Br J Pharmacol 101:382–386

    Google Scholar 

  27. Fredholm BB (1980) Are methylxanthine effects due to antagonism of endogenous adenosine? TIPS 1:129–132

    Google Scholar 

  28. Fredholm BB (1985) On the mechanism of action of theophylline and caffeine. Acta Med Scand 217:145–153

    Google Scholar 

  29. McPhee MD, Whiting SJ (1989) The effect of adenosine and adenosine analogues on methylxanthine-induced hypercalciuria in the rat. Can J Physiol Pharmacol 67:1278–1282

    Google Scholar 

  30. Lerner UH, Sahlberg K, Fredholm BB (1987) Characterization of adenosine receptors in bone. Studies on the effect of adenosine analogues on cyclic AMP formation and bone resorption in cultured mouse calvaria. Acta Physiol Scand 131:287–296

    Google Scholar 

  31. Lerner UH, Fredholm BB, Ransjö M (1986) Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro. Biochem J 240:529–539

    Google Scholar 

  32. Ransjö M, Lerner UH (1987) Effects of choleratoxin on cyclic AMP accumulation and bone resorption in cultured mouse calvaria. Biochim Biophys Acta 930:378–391

    Google Scholar 

  33. Ransjö M, Fredholm BB, Lerner UH (1988) Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation. Bone Miner 3:225–234

    Google Scholar 

  34. Yeh JK, Aloia JF (1986) Differential effect of caffeine administration on calcium and vitamin D metabolism in young and adult rats. J Bone Miner Res 1:251–258

    Google Scholar 

  35. Johansson C, Mellström D, Lerner UH, Österberg T (1992) Coffee drinking: a minor risk factor for bone loss and fractures. Age Ageing 21:20–26

    Google Scholar 

  36. Glajchen N, Ismail F, Epstein S, Jowell PS, Fallon M (1986) The effect of chronic caffeine administration on serum markers of bone mineral metabolism and bone histomorphometry in the rat. Calcif Tissue Int 43:277–280

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral Cell Biology, University of Umeå, S-901 87, Umeå, Sweden

    Ulf H. Lerner

  2. Department of Geriatrics, University of Gothenburg, Gothenburg, Sweden

    Dan Mellström

Authors
  1. Ulf H. Lerner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dan Mellström
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lerner, U.H., Mellström, D. Caffeine has the capacity to stimulate calcium release in organ culture of neonatal mouse calvaria. Calcif Tissue Int 51, 424–428 (1992). https://doi.org/10.1007/BF00296675

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00296675

Key words

Search

Navigation